# Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

> **NCT02289274** · PHASE1 · WITHDRAWN · sponsor: **NVP Healthcare**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NVP-1203
- **DRUG:** Eperisone SR tab. + and Airtal tab.

## Key facts

- **NCT ID:** NCT02289274
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** internal decision
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289274, "Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02289274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*